As shown in Figure 1, there were 20 studies that examined high mRNA expression levels of FABP6 in CRC tissues, to which we assigned a significance level of p < 0.05, multiple of change of 1.5, and a gene rank in the top 10%. This evidence concerns the gene FABP6 and colorectal carcinoma.